Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.
3.

A Fennoscandian focus of multiple sclerosis.

Kurtzke JF.

Neurology. 1968 Jan;18(1 Pt 1):16-20. No abstract available.

PMID:
5688791
4.

Further features of the Fennoscandian focus of multiple sclerosis.

Kurtzke JF.

Acta Neurol Scand. 1974;50(4):478-502. No abstract available.

PMID:
4852113
5.

Further considerations on the geographic distribution of multiple sclerosis.

Kurtzke JF.

Acta Neurol Scand. 1967;43(3):283-98. No abstract available.

PMID:
6049787
6.
7.

[Incidence of multiple sclerosis in Scandinavia and Finland].

Koch-Henriksen NJ.

Ugeskr Laeger. 1996 May 20;158(21):2966-9. Danish.

PMID:
8686032
8.

Multiple sclerosis in Scandinavia and Finland.

Koch-Henriksen N.

Acta Neurol Scand Suppl. 1995;161:55-9.

PMID:
7653247
9.

Between-country variation in the utilization of antihypertensive agents: Guidelines and clinical practice.

Stolk P, Van Wijk BL, Leufkens HG, Heerdink ER.

J Hum Hypertens. 2006 Dec;20(12):917-22. Epub 2006 Sep 21.

PMID:
16988753
10.

Gender differences in multiple sclerosis epidemiology and treatment response.

Magyari M.

Dan Med J. 2016 Mar;63(3). pii: B5212. Review.

PMID:
26931196
11.
12.

On the fine structure of the distribution of multiple sclerosis.

Kurtzke JF.

Acta Neurol Scand. 1967;43(3):257-82. No abstract available.

PMID:
6049786
13.

A comparative study of educational inequality in the risk of stillbirth in Denmark, Finland, Norway and Sweden 1981-2000.

Rom AL, Mortensen LH, Cnattingius S, Arntzen A, Gissler M, Andersen AM.

J Epidemiol Community Health. 2012 Mar;66(3):240-6. doi: 10.1136/jech.2009.101188. Epub 2010 Oct 5.

PMID:
20924053
14.

Future outlook for mortality decline in the world.

Bourgeois-pichat J.

Popul Bull UN. 1978;(11):12-41. No abstract available.

PMID:
12310586
15.

Scandinavian research in anaesthesiology 1981-2000: visibility and impact in EU and world context.

Skram U, Larsen B, Ingwersen P, Viby-Mogensen J.

Acta Anaesthesiol Scand. 2004 Sep;48(8):1006-13.

PMID:
15315619
16.

End-of-life decision-making in six European countries: descriptive study.

van der Heide A, Deliens L, Faisst K, Nilstun T, Norup M, Paci E, van der Wal G, van der Maas PJ; EURELD consortium.

Lancet. 2003 Aug 2;362(9381):345-50.

PMID:
12907005
17.

An ecological study of industry in a high-risk region of multiple sclerosis.

Boström I, Landtblom AM, Lauer K.

J Neurol Sci. 2011 Dec 15;311(1-2):50-7. doi: 10.1016/j.jns.2011.09.005. Epub 2011 Oct 6.

PMID:
21982618
18.

A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis.

Akesson E, Oturai A, Berg J, Fredrikson S, Andersen O, Harbo HF, Laaksonen M, Myhr KM, Nyland HI, Ryder LP, Sandberg-Wollheim M, Sorensen PS, Spurkland A, Svejgaard A, Holmans P, Compston A, Hillert J, Sawcer S.

Genes Immun. 2002 Aug;3(5):279-85.

19.

Organic solvents and the risk of multiple sclerosis.

Riise T, Moen BE, Kyvik KR.

Epidemiology. 2002 Nov;13(6):718-20.

PMID:
12410015
20.

Timing of birth and risk of multiple sclerosis: population based study.

Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC; Canadian Collaborative Study Group.

BMJ. 2005 Jan 15;330(7483):120. Epub 2004 Dec 7.

Supplemental Content

Support Center